Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
Innovations in the treatment of invasive cervical cancer. [electronic resource] by
- Stehman, Frederick B
- Rose, Peter G
- Greer, Benjamin E
- Roy, Michel
- Plante, Marie
- Penalver, Manuel
- Jhingran, Anuja
- Eifel, Patricia
- Montz, Fredrick
- Wharton, J Taylor
Producer: 20031202
In:
Cancer vol. 98
Availability: No items available.
|
|
|
11.
|
|
|
|
12.
|
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study. [electronic resource] by
- Farley, John
- Fuchiuji, Sartoru
- Darcy, Kathleen M
- Tian, Chunqiao
- Hoskins, William J
- McGuire, William P
- Hanjani, Parviz
- Warshal, David
- Greer, Benjamin E
- Belinson, Jerome
- Birrer, Michael J
Producer: 20090518
In:
Gynecologic oncology vol. 113
Availability: No items available.
|
|
|
13.
|
Patient reported outcomes of a randomized, placebo-controlled trial of bevacizumab in the front-line treatment of ovarian cancer: a Gynecologic Oncology Group Study. [electronic resource] by
- Monk, Bradley J
- Huang, Helen Q
- Burger, Robert A
- Mannel, Robert S
- Homesley, Howard D
- Fowler, Jeffrey
- Greer, Benjamin E
- Boente, Matthew
- Liang, Sharon X
- Wenzel, Lari
Producer: 20130624
In:
Gynecologic oncology vol. 128
Availability: No items available.
|
|
|
14.
|
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. [electronic resource] by
- Ozols, Robert F
- Bundy, Brian N
- Greer, Benjamin E
- Fowler, Jeffrey M
- Clarke-Pearson, Daniel
- Burger, Robert A
- Mannel, Robert S
- DeGeest, Koen
- Hartenbach, Ellen M
- Baergen, Rebecca
Producer: 20031002
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 21
Availability: No items available.
|
|
|
15.
|
Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study. [electronic resource] by
- Lavey, Robert S
- Liu, P Y
- Greer, Benjamin E
- Robinson, William R
- Chang, Pui C
- Wynn, Raymond B
- Conrad, Marcel E
- Jiang, Caroline
- Markman, Maurie
- Alberts, David S
Producer: 20041102
In:
Gynecologic oncology vol. 95
Availability: No items available.
|
|
|
16.
|
Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study. [electronic resource] by
- Greer, Benjamin E
- Bundy, Brian N
- Ozols, Robert F
- Fowler, Jeffrey M
- Clarke-Pearson, Daniel
- Burger, Robert A
- Mannel, Robert
- DeGeest, Koen
- Hartenbach, Ellen M
- Baergen, Rebecca N
- Copeland, Larry J
Producer: 20051104
In:
Gynecologic oncology vol. 99
Availability: No items available.
|
|
|
17.
|
Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer. [electronic resource] by
- Han, Ernest S
- Burger, Robert A
- Darcy, Kathleen M
- Sill, Michael W
- Randall, Leslie M
- Chase, Dana
- Parmakhtiar, Basmina
- Monk, Bradley J
- Greer, Benjamin E
- Connelly, Patrick
- Degeest, Koen
- Fruehauf, John P
Producer: 20101124
In:
Gynecologic oncology vol. 119
Availability: No items available.
|
|
|
18.
|
Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: an NRG Oncology/GOG study. [electronic resource] by
- Ferriss, James S
- Java, James J
- Bookman, Michael A
- Fleming, Gini F
- Monk, Bradley J
- Walker, Joan L
- Homesley, Howard D
- Fowler, Jeffrey
- Greer, Benjamin E
- Boente, Matthew P
- Burger, Robert A
Producer: 20160107
In:
Gynecologic oncology vol. 139
Availability: No items available.
|
|
|
19.
|
Incorporation of bevacizumab in the primary treatment of ovarian cancer. [electronic resource] by
- Burger, Robert A
- Brady, Mark F
- Bookman, Michael A
- Fleming, Gini F
- Monk, Bradley J
- Huang, Helen
- Mannel, Robert S
- Homesley, Howard D
- Fowler, Jeffrey
- Greer, Benjamin E
- Boente, Matthew
- Birrer, Michael J
- Liang, Sharon X
Producer: 20120105
In:
The New England journal of medicine vol. 365
Availability: No items available.
|
|
|
20.
|
Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study. [electronic resource] by
- Burger, Robert A
- Brady, Mark F
- Bookman, Michael A
- Monk, Bradley J
- Walker, Joan L
- Homesley, Howard D
- Fowler, Jeffrey
- Greer, Benjamin E
- Boente, Matthew
- Fleming, Gini F
- Lim, Peter C
- Rubin, Stephen C
- Katsumata, Noriyuki
- Liang, Sharon X
Producer: 20140723
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 32
Availability: No items available.
|